Literature DB >> 7973108

Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases.

J Mañá1, A Salazar, F Manresa.   

Abstract

The prognosis of sarcoidosis is difficult to establish and it depends mainly on the persistence of activity over time and the degree of functional impairment of the involved organs. The aim of this study was to identify factors predicting persistence of disease activity at diagnosis. In a 14-year period (1974-1987), 209 patients were diagnosed with sarcoidosis at Bellvitge Hospital, a 1,000-bed teaching institution in Barcelona, Spain. One hundred ninety-three patients were followed up and included in the study. Clinical and radiological data were collected at diagnosis and a definition of disease activity was established. A Cox proportional-hazards regression model identified the following variables as independently influencing the persistence of activity: absence of erythema nodosum (risk ratio, RR = 2.37; 95% confidence interval, CI: 1.54-3.66), pulmonary infiltrates in chest x-ray (RR = 1.89, 95% CI: 1.28-2.8), splenomegaly (RR = 3.67, 95% CI: 1.46-9.23), age > or = 40 years (RR = 1.01, 95% CI: 1.006-1.03), and absence of lymphadenopathy in chest x-ray (RR = 2.26, 95% CI: 1.08-4.77). We suggest that the identification of factors predicting persistence of sarcoidosis activity at diagnosis may help to establish the prognosis of the disease and therefore improve the therapeutic approach.

Entities:  

Mesh:

Year:  1994        PMID: 7973108     DOI: 10.1159/000196341

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  11 in total

1.  Sarcoidosis as a risk factor for venous thromboembolism.

Authors:  Anna Goljan Geremek; Witold Tomkowski; Marcin Geremek; Elżbieta Puścińska; Grzegorz Małek; Adam Nowiński; Michal Bednarek; Paweł Śliwiński
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  Tattoo Sarcoidosis.

Authors:  Alexis Lyons; Gretchen Brayman; Sami Tahhan
Journal:  J Gen Intern Med       Date:  2017-08-28       Impact factor: 5.128

Review 3.  [Musculoskeletal manifestations of sarcoidosis].

Authors:  P Korsten; G Chehab
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

4.  Recurrence of Lofgren's syndrome 32 years later. A case report and review of the literature.

Authors:  Adriana Iriarte; Manuel Rubio-Rivas; Xavier Corbella; Juan Mañá
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

5.  Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy.

Authors:  Sabrina Marangoni; Vincenza Argentiero; Bruno Tavolato
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

Review 6.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 7.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

Review 8.  The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.

Authors:  Andor W J M Glaudemans; Erik F J de Vries; Filippo Galli; Rudi A J O Dierckx; Riemer H J A Slart; Alberto Signore
Journal:  Clin Dev Immunol       Date:  2013-08-21

Review 9.  Venous thromboembolism and sarcoidosis: co-incidence or coexistence?

Authors:  Anna Goljan-Geremek; Marcin Geremek; Elzbieta Puscinska; Pawel Sliwinski
Journal:  Cent Eur J Immunol       Date:  2016-01-15       Impact factor: 2.085

10.  Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis.

Authors:  Yusuke Inoue; Naoki Inui; Dai Hashimoto; Noriyuki Enomoto; Tomoyuki Fujisawa; Yutaro Nakamura; Takafumi Suda
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.